1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
67BF2D2FA917AE61E85257D620064EAC4
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-competing-in-an-outcomes-oriented-healthcare-world?opendocument
18
19opendocument
203.94.129.211
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing New Product Development and Launch Planning and Coordinating Launch Launch Strategy and Structure

Competing in An Outcomes-Oriented Healthcare World

DB Image

ID: 5332


Features:

22 Info Graphics

5 Data Graphics

30 Metrics

5 Narratives


Pages/Slides: 30


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
STUDY OVERVIEW

As payers flex increasing muscle in the pharmaceutical marketplace, cost and effectiveness have become key components of a product's success. Health outcomes research has become a principal way of gauging effectiveness and assessing appropriate cost.


This 30-page slide deck is from a presentation by Best Practices, LLC CEO Chris Bogan. The presentation includes qualitative and quantitative data that examines the factors behind the growing interest in outcomes research among both payers and pharma. Likewise, the presentation presents a picture of what pharma companies should be doing now in order to prepare for a future in an outcomes-oriented healthcare world.


SAMPLE KEY METRICS

  • Expected increase/decrease investment for health outcomes research over next two years
  • Expected increase/decrease investment for innovative outcomes research over next two years
  • Expected increase/decrease investment for patient-reported outcomes research over next two years
  • Average percentage of patient support budget invested at each stage of patient journey
  • Expected investment for comparative effectiveness research over next two years

METHODOLOGY

Best Practices, LLC pulled data from several BP studies and conducted secondary research to create this presentation on the growing role outcomes research is having in the pharmaceutical sector.

Industries Profiled:
Market Research; Manufacturing; Medical Device; Pharmaceutical; Financial Services; Service; Retail; Research; Computer Software; Diagnostic; Health Care; Transportation; Biotech; Clinical Research; Consulting; Distribution; Insurance; Hospitality; Telecommunications; Technology; Professional Services; High Tech; Automobile; Utilities; Energy; Consumer Products; Chemical; Medical; Electronics; Laboratories; Biopharmaceutical; Banking; Computers; Entertainment; Internet; Computer Hardware; Aerospace; Academic; Media; Education; Newspapers; Government; Shipping; Science; Office Supplies; Marketing; Office Equipment; Cable; Advertising; Defense; Military; Diversified; Sports; Technology; Public Relations; Multiple; Communications; Logistics; Publishing; Real Estate; Construction; Architecture; Engineering; Aviation; Legal; Test Industry; Non-Profit; Business; Orthopaedics


Companies Profiled:

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.